INTERCEPT PHARMACEUTICALS, INC.·4

Jul 6, 7:03 PM ET

Weyer Christian 4

4 · INTERCEPT PHARMACEUTICALS, INC. · Filed Jul 6, 2020

Insider Transaction Report

Form 4
Period: 2020-07-01
Weyer Christian
EVP Research and Development
Transactions
  • Tax Payment

    Common Stock

    2020-07-01$46.52/sh46$2,14016,737 total
Footnotes (1)
  • [F1]Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person.

Documents

1 file
  • 4
    tm2024073d8_4.xmlPrimary

    OWNERSHIP DOCUMENT